Package Leaflet:information for the user
Sirdalud 2 mg tablets
Tizanidine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the package leaflet:
Sirdalud belongs to a group of medicines called muscle relaxants (medicines used to relax muscles). It is indicated for the treatment of muscle problems associated with:
chronic hip disease
Do not take Sirdalud
Warnings and precautions
Talk to your doctor or pharmacist before you start taking this medicine, especially:
Taking Sirdalud with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines:
Sirdalud may increase the effects of:
Taking Sirdalud with food and drinks
Alcohol may increase the sedative effects of Sirdalud, so it is recommended that you do not drink alcohol while taking this medicine.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Do not take this medicine during pregnancy or breastfeeding. A pregnancy test is recommended before starting treatment.
Use contraceptive methods in women of childbearing age during treatment and at least until one day after stopping it.
Driving and using machines
Sirdalud may make you feel drowsy, dizzy, and cause sweating, see flashes, so you should not drive or use hazardous machinery while taking this medicine.
Important information about some of the ingredients of Sirdalud
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
Follow the instructions for administration of this medicine contained in this leaflet or as indicated by your doctor. If you are unsure, ask your doctor or pharmacist.
Remember to take your medicine. Your doctor will tell you the duration of your treatment with Sirdalud. Do not stop it before or prolong it.
Swallow the tablets with a glass of water. The tablets can be broken in half.
The recommended dose is:
Adults
One or two tablets (2 mg to 4 mg of tizanidine) three times a day. In severe cases, it can be increased up to a maximum daily dose of eight tablets (16 mg of tizanidine). Patients with neurological disorders should not take more than eighteen tablets per day (36 mg of tizanidine).
Patients with kidney disease
A dose reduction may be necessary if you have kidney disease, so you should inform your doctor so that they can adjust the dose accordingly.
Patients with liver disease
A dose reduction or contraindication of the medicine may be necessary if you have liver disease, so you should inform your doctor so that they can adjust the dose accordingly.
Use in children
Experience in children is limited, therefore, its use is not recommended in children under 18 years of age.
Elderly
Experience in the elderly is limited. Treatment should be started with the lowest dose and your doctor will adjust the dose accordingly.
If you take more Sirdalud than you should
Tell your doctor or pharmacist or go to the nearest hospital. You may need urgent medical attention. The symptoms of overdose are nausea, vomiting, low blood pressure, slow heart rate, dizziness, drowsiness, pupil constriction, agitation, difficulty breathing, or coma.
In cases of overdose or accidental ingestion, consult the Toxicology Information Service. Telephone 91 562 04 20. It is recommended to take the packaging and the leaflet of the medicine to the healthcare professional.
If you forget to take Sirdalud
Do not take a double dose to make up for forgotten doses. Take the missed dose as soon as possible, unless it is almost time for the next dose, in which case skip the missed dose and take the next dose when it is due.
If you stop taking Sirdalud
Do not change or stop taking Sirdalud without first consulting your doctor. Your doctor will gradually reduce the dose before stopping treatment completely. This will prevent worsening and reduce the risk of hypertension (high blood pressure, headache, dizziness) or tachycardia (rapid heart rate).
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very common(at least 1 in 10 patients) are:
Nervous system disorders: drowsiness, dizziness
Gastrointestinal disorders: gastrointestinal disturbances, dry mouth
General disorders and administration site conditions: fatigue
Musculoskeletal and connective tissue disorders: muscle weakness
Common(at least 1 in 100 patients but less than 1 in 10 patients) are:
Psychiatric disorders: insomnia, sleep disorders
Vascular disorders: decreased blood pressure. Consult your doctor immediately.
Gastrointestinal disorders: nausea
Investigations: a transient increase in liver enzymes (transaminases) may occur.
Uncommon(at least 1 in 1000 patients but less than 1 in 100 patients) are:
Cardiac disorders: slow heart rate.
Frequency not known(cannot be estimated from the available data):
Immune system disorders: allergic reactions, severe allergic reactions including difficulty breathing, dizziness (anaphylaxis) and swelling mainly of the face and throat (angioedema). Consult your doctor immediately.
Psychiatric disorders: hallucinations, confusion. Consult your doctor immediately.
Nervous system disorders: vertigo, speech confusion
Vascular disorders: fainting
Eye disorders: blurred vision
Gastrointestinal disorders: stomach pain, vomiting
Hepatobiliary disorders: acute hepatitis, liver failure. Consult your doctor immediately.
Skin and subcutaneous tissue disorders: skin inflammation with rash (dermatitis), skin redness (erythema), itching (pruritus), and itchy rash (urticaria and rash).
General disorders: loss of vitality and withdrawal symptoms (rebound hypertension and tachycardia).
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
No special storage conditions are required.
Do not use this medicine after the expiry date stated on the packaging. The expiry date is the last day of the month stated.
Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. They will dispose of it in an environmentally friendly way. If you have any further questions, ask your pharmacist.
Composition ofSirdalud
Each tablet contains 2 mg of tizanidine (as hydrochloride).
Appearance of the product and pack contents
Sirdalud 2 mg tablets are presented as a circular tablet, white in color, scored with the mark OZ. Each pack contains 30 tablets.
Marketing authorisation holder
BEXAL FARMACÉUTICA, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Novartis Farmacéutica, S. A.
Gran Vía de les Corts Catalanes, 764
08013 Barcelona, Spain
or
Novartis Pharma GmbH
Roonstrasse 25
90429 Nuremberg, Germany
or
Lek Pharmaceuticals d.d.
Verovskova Ulica 57,
Ljubljana 1526,
Slovenia
Date of last revision of this leaflet:January 2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.gob.es
The average price of SIRDALUD 2 mg TABLETS in October, 2025 is around 3.68 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.